Markets
markets

Teladoc falls after sickly earnings report

Teladoc is down more than 12% after it reported bigger-than-expected losses after market close on Wednesday.

The company reported a loss of $0.28 per share, compared to the $0.26 analysts polled by FactSet were expecting. Teladoc reported $640 million in quarterly sales, in line with analysts’ estimates, but down from the $661 million it reported in the same period last year.

Teladoc said that was hurt by a 10% decrease in revenue from BetterHelp, its online therapy platform. TALK, a competitor to BetterHelp, reported last week that its sales grew, but by less than analysts hoped.

For the full year 2024, Teladoc’s sales stayed virtually flat and its losses grew. The company bled $1 billion in 2024, its worst year since 2022 when it incurred a $13.4 billion noncash goodwill impairment charge related to its acquisition of Livongo, a chronic-condition management company.

Excluding 2022, the year Teladoc just reported was its worst for profitability since at least 2014.

Teladoc said that was hurt by a 10% decrease in revenue from BetterHelp, its online therapy platform. TALK, a competitor to BetterHelp, reported last week that its sales grew, but by less than analysts hoped.

For the full year 2024, Teladoc’s sales stayed virtually flat and its losses grew. The company bled $1 billion in 2024, its worst year since 2022 when it incurred a $13.4 billion noncash goodwill impairment charge related to its acquisition of Livongo, a chronic-condition management company.

Excluding 2022, the year Teladoc just reported was its worst for profitability since at least 2014.

More Markets

See all Markets
markets

Tariff losers are today’s big winners as Supreme Court seen as likely to strike down Trump’s IEEPA tariffs

US companies in the crossfire of wide-ranging tariffs imposed by the Trump administration are surging as the Supreme Court hears oral arguments on the legality of levies imposed under the International Emergency Economic Powers Act and prediction markets conclude that the ruling is not likely to go the government’s way.

Event contracts offered by Polymarket ascribe roughly 30% odds of the Supreme Court ruling in favor of the existing tariff regime, a number that got as low as 18% around 11:30 a.m. ET. Earlier this morning, that likelihood was briefly above 50%.

A basket of stocks deemed to be the biggest losers from Trump’s tariffs compiled by UBS is having one of its best days of 2025, up 3.7% as of 1:48 p.m. ET.

Rivian’s standout post-earnings rally is giving that index a big boost, but other gainers include Gap,American Eagle, Yeti, Fluence Energy, Nike, Stanley Black & Decker, RH, Deckers Outdoor, Under Armour, Wayfair, Best Buy, Williams-Sonoma, Crocs,Five Below, and Dollar Tree.

WisdomTree macro strategist Sam Rines recently warned that the Supreme Court striking down IEEPA tariffs could turn into a “be careful what you wish for” or “pyrrhic victory”-type scenario, as the Trump administration would likely a) talk more about tariffs, an issue that the stock market is keen to move on from and b) pursue alternative mechanisms to get similar levies back on.

US airlines climb as President Trump shifts his tone about the urgency of ending the shutdown

Shares of US airlines are climbing as the government shutdown stretches into a record 36th day.

Stocks of several carriers, including Delta Air Lines, United Airlines, and American Airlines, rose significantly following an apparent change of tune from President Trump, who on Wednesday told Senate Republicans that they “must get the government back open soon, and really immediately.”

It’s a shift from the president, who’s traveled frequently during the shutdown and stuck firmly to the idea that the administration wouldn’t negotiate with Democrats before the government reopened.

Airlines had tumbled on Tuesday, following comments from Transportation Secretary Duffy that the US could close parts of its airspace amid an air traffic controller shortage that’s been escalated by the shutdown.

markets

Top Trump trade hit by Trump tariffs

In the early days of Trump 2.0, Axon, the maker of Taser, body cameras, and other gear for police and security forces, was a top Trump trade.

That is, it was one of the group of companies whose share prices soared on expectations of big changes — in this case a surge of spending on police and immigration enforcement — under the new administration.

And sales of the company’s security products, under its Connected Products division, did rise. But in the just-reported third quarter, costs rose more. And one of those rising costs was the Trump administration’s tariffs.

In its post-earnings conference call, Axon officials blamed tariffs for a large part of the earnings miss that sent the stock plummeting by roughly 20% in the after-hours session Tuesday.

“The impact from tariffs is obviously hitting the Connected Devices business overall. This was the first quarter that we had a full quarter of impact from tariffs,” Axon CFO and COO Brittany Bagley told analysts on the call. “So as we look at the year-over-year step down, that really is attributable to tariffs.”

She continued, “As long as tariffs stay in place, I view that as sort of a onetime adjustment. So now that’s baked into the gross margins.”

Clearly the market didn’t like the sound of that. But perhaps those tariffs may not stay in place.

Late in the morning, Axon sharply cuts its losses on the day — it had been down as much as 20% — as oral arguments in the Supreme Court case to determine the legality of President Trump’s tariff regime got underway. On balance, its seems the administration’s arguments were getting a chilly reception from the justices.

And sales of the company’s security products, under its Connected Products division, did rise. But in the just-reported third quarter, costs rose more. And one of those rising costs was the Trump administration’s tariffs.

In its post-earnings conference call, Axon officials blamed tariffs for a large part of the earnings miss that sent the stock plummeting by roughly 20% in the after-hours session Tuesday.

“The impact from tariffs is obviously hitting the Connected Devices business overall. This was the first quarter that we had a full quarter of impact from tariffs,” Axon CFO and COO Brittany Bagley told analysts on the call. “So as we look at the year-over-year step down, that really is attributable to tariffs.”

She continued, “As long as tariffs stay in place, I view that as sort of a onetime adjustment. So now that’s baked into the gross margins.”

Clearly the market didn’t like the sound of that. But perhaps those tariffs may not stay in place.

Late in the morning, Axon sharply cuts its losses on the day — it had been down as much as 20% — as oral arguments in the Supreme Court case to determine the legality of President Trump’s tariff regime got underway. On balance, its seems the administration’s arguments were getting a chilly reception from the justices.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.